Yüklüyor......
Stem cell mobilization with plerixafor and healing of diabetic ischemic wounds: A phase IIa, randomized, double‐blind, placebo‐controlled trial
Bone marrow‐derived cells contribute to tissue repair, but traffic of hematopoietic stem/progenitor cells (HSPCs) is impaired in diabetes. We therefore tested whether HSPC mobilization with the CXCR4 antagonist plerixafor improved healing of ischemic diabetic wounds. This was a pilot, phase IIa, dou...
Kaydedildi:
| Yayımlandı: | Stem Cells Transl Med |
|---|---|
| Asıl Yazarlar: | , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley & Sons, Inc.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7445026/ https://ncbi.nlm.nih.gov/pubmed/32485785 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sctm.20-0020 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|